Sponsor or institution
Clinical trials and research at Chengdu Zenitar Biomedical Technology Co., Ltd
As of November 12, 2026, Find a Trial lists 8 clinical trials run by Chengdu Zenitar Biomedical Technology Co., Ltd that are recruiting, in China. By phase: Phase 2 (3), Phase 3 (2), Phase 1/2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 1Country
Newest trials
All recruiting trials (8)
-
ZL-65 tablet in healthy adults: safety, tolerability, and pharmacokinetics in China
This first‑in‑humans study tests whether a single dose of ZL‑65 is safe and well tolerated in healthy adults in China and looks at how the body handles the drug, including the effect of food on absorption.
-
Flonoltinib maleate tablets for adults with JAK-inhibitor refractory or intolerant myelofibrosis
This trial will try once-daily flonoltinib maleate tablets, taken on an empty stomach, in adults with moderate-to-high risk myelofibrosis whose disease returned, did not respond to, or who could not tolerate JAK inhibitor therapy.
-
Flonoltinib maleate treatment for intermediate- or high-risk myelofibrosis
This trial will test flonoltinib versus ruxolitinib in adults 18–80 with intermediate- or high-risk myelofibrosis and enlarged spleens to see if flonoltinib better reduces spleen size and symptoms.
-
Flonoltinib maleate tablets for adults with polycythemia vera (dose-finding and expansion)
This trial will test whether flonoltinib maleate tablets help adults with polycythemia vera who are resistant or intolerant to hydroxyurea or interferon.
-
ZL-82 tablets for adults with moderate to severe atopic dermatitis
This trial will test whether taking ZL-82 tablets daily for 16 weeks can reduce eczema severity and itching in adults with moderate to severe atopic dermatitis compared with a placebo.
-
Purinostat mesylate injections versus oral selinexor for relapsed or refractory diffuse large B‑cell lymphoma
This study tests whether purinostat mesylate injections work better than oral selinexor for adults with relapsed or refractory diffuse large B‑cell lymphoma.
-
Combining Purinostat Mesylate with Pomalidomide and Dexamethasone for Multiple Myeloma
This study is testing if a new combination of medications can be safely used to help people with relapsed or hard-to-treat multiple myeloma.
-
Evaluating Purinostat Mesylate for Advanced Solid Tumors
This study is testing a new drug called Purinostat Mesylate to see how safe it is and if it can help people with advanced solid tumors.
Quick answers
How many clinical trials run by Chengdu Zenitar Biomedical Technology Co., Ltd are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 2, Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.